News|Videos|August 31, 2026

The future of PMOS care and caution around GLP-1 therapy and weight loss

Experts weigh GLP-1 therapy's promise for PMOS against the risks of overly rapid weight loss in teens.

Welcome back to this Contemporary OB/GYN, Contemporary Pediatrics, and Patient Care Online Special Report series, exploring the global consensus on renaming polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS). Across 5 episodes, our host and experts examine what this shift means for diagnosis, management, and patient care across the reproductive lifespan.